iHEALTH - Instituto Milenio en Ingeniería e Inteligencia Artificial para la Salud

2 de septiembre 2026

Translational Biomarkers in Rectal Cancer

Fecha: 2 de septiembre 2026
Horario: 09:00 - 12:30
Auditorio Barahona, Edificio Académico Facultad de Medicina de la Pontificia Universidad Católica de Chile, Diagonal Paraguay 362, Santiago
Organiza: UC–iHEALTH / CECAN

Programa

Session 1 — Clinical and Biological Foundations

Hora

Presentación

09:00–09:20

Current Clinical Decision-Making in Locally Advanced Rectal Cancer: Where Are the Remaining Gaps?
Pablo Muñoz · Radiation Oncologist, UC

09:20–09:40

MRI Assessment of Treatment Response: From Visual Evaluation to Quantitative Imaging Biomarkers
Cecilia Besa · Radiologist, UC

09:40–10:00

Beyond the pathology report: understanding neoadjuvant treatment response in rectal cancer
Patricia García, PhD · Department of Pathology, UC / CECAN

10:00–10:30

Coffee Break

Session 2 — Translational Biomarkers and Emerging Technologies

Hora

Presentación

10:30–10:55

Radiomics and Quantitative Imaging: Principles, Challenges and Opportunities for Clinical Translation
Paola Caprile · Medical Physicist, UC / iHEALTH

10:55–11:15

Patient-derived organoids for treatment response assessment in rectal cancer
Diego Muñoz, PhD · Department of Pathology, UC / CECAN
Patricia García, PhD · Department of Pathology, UC / CECAN

11:15–11:35

Multimodal Biomarkers: Integrating Imaging, Omics and Artificial Intelligence for Treatment Response Prediction
Liya Muthukulathil Antony · UC / iHEALTH

11:45–12:15

Imaging Biomarkers in Rectal Cancer: Reproducibility, Clinical Validation and Future Directions (to be confirmed)
Stephanie Nougaret · University of Montpellier, France

12:15–12:30

Closing Remarks and Future Directions of the UC–iHEALTH–CECAN Translational Platform


Inscripciones: https://forms.gle/nMLzsc2gmzmrtwPu7